礼来(LLY.N)美股盘前跌幅扩大至11%，实验显示，礼来口服药物Orforglipron平均减重11.2%。

Disclaimer:

1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.

2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.